• Home
  • Study Details

ICE - Improving Cognition via Exercise in Schizophrenia

Participants are needed for a research study on the influence of physical exercise on cognitive functioning in individuals with schizophrenia and related disorders.

Age & Gender

  • 18 years ~ 55 years
  • Male, Female


North Carolina (Statewide)

What will be asked of you

Following the baseline research assessment, participants will be randomized into one of two groups, aerobic exercise training or stretching and toning training. Participants in both groups will take part in a 12-week, 3 times per week, 1-hour training program. There will also be assessment at week 6 and at week 12.


$265.00 over the course of the study., Possible travel compensation

In-person visits : 36
Total length of participation : 12 weeks

Looking for Specific Volunteers

Able to participate:

  • Have a diagnosis of schizophrenia, schizoaffective disorder, or schizophreniform disorder
  • Are currently taking antipsychotic medication
  • No more than moderate degree of disorganization

Not eligible if:

  • Street drug use within the past 4 weeks
  • History of severe hypertension or serious cardiac conditions
  • History of active suicidal ideation, serious self-destructive behavior, violence or aggressive behavior (previous 2 years)
  • History of neurological or medical conditions known to seriously affect the brain
  • Currently pregnant or nursing

Contact the Team

Visit Location

100% Remote (online, phone, text)

Additional Study Information

Principal Investigator

Fred Jarskog
Psychiatry - Research

Study Topics

Mental and Emotional Health

IRB Number


logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research
Research for Me logo

Copyright © 2013-2020 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.


  • This email address is being protected from spambots. You need JavaScript enabled to view it.